Alto Neuroscience, Inc. (ANRO) Tops Q3 EPS by 12c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.52), $0.12 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Simmons First National Corp (SFNC) Misses Q2 EPS by 2c
• After-Hours Stock Movers: NFLX, ISRG, KO, AA, RGNX
• Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue